At ICV Sonoma 2017, we will bring visibility to social impact companies that are shaping the future of traditional industries and organizations that are addressing societal challenges front and center to an investment community by virtue and wealth that can advance corporate responsibility, capitalize businesses at significant levels, and influence systemic change.

ICV Sonoma 2017 is designed to deliver diverse content to Family Offices who are allocating their capital across asset classes; carefully examining the interconnected risks that may disrupt a well-thought-out portfolio designed for future generations; and, improving the wellbeing of humankind through their philanthropy.

This one day event will be packed with substantive opportunity and expert presentations by thought leaders and institutional investors who leverage their talent, influence and capital to identify and grow businesses.



Family Office Roundtable

Members of single family offices will speak openly on a wide range of topics such as sourcing deal flow, direct investing, allocating to professional managers, and family governance.

  • Dave Furneaux, Founder of Furneaux Capital, invests in breakthrough markets and ideas. Dave is also Founder and Managing Partner of Kodiak Venture Partners, which focuses on seed and early stage investments in emerging communications/wireless, semiconductor/equipment, software/services, internet/new media, and life technology companies. Founded in late 1999, Kodiak manages three main funds totaling $681M and targets companies in Eastern North America, focusing efforts in Boston, New York and Eastern Canada. The firm’s investment approach is to work as a close partner with strong entrepreneurs in all aspects of the company’s formation and growth. Kodiak views itself as an extension to the teams it works with.
  • Kevin Primat is an entrepreneur, investor, and voracious reader. Descendent of the Schlumberger founders, the Oil and Gas company, he oversees the Investment Committee at the Primwest Family Office. While studying at the Architectural Association Kevin developed an overwhelming desire to connect design to technology. His projects were published in magazines, University publications, and selected as year-end’s best work. Additionally to founding Primed, he invested in a number of deep industry data analytics companies – Tachyus, Converge, Kayrros – and served as Chairman of Kayrros’ Board of Directors.
  • Robert Smith entered Wall Street with lessons passed down from four generations of family members who worked in the investment industry before him. Over the course of his career, he managed sales and trading teams at leading financial institutions, and built capital markets and international equities businesses. In 2014, Robert founded ICV to bring together his networks of family offices and institutional investors to evaluate opportunities that create a social impact beyond a financial return. He serves as Business Strategy Advisor to New Frontier Bio, a multi-asset holding company, which leverages the long-term involvement of the Kennedy family in healthcare to identify, finance and develop novel medical technologies from inception through clinical proof of concept. He serves as Senior Advisor for Fundraising and Partnerships to the Permanent Secretariat of the World Summit of Nobel Peace Laureates. Robert serves on the boards of Childhood Cancer Kids, The Children’s Village, Tuesday’s Children, and The Harmon Foundation.
  • Phin Upham, Principal of Thiel Capital, an investment firm founded by Peter Thiel. He previously worked at Morgan Stanley in the investment banking division and as a journalist at National Post/UPI. He has been a visiting scholar at Columbia Business School and the New York University Department of Economics. He is a term member of the Council on Foreign Relations. Upham earned a B.A. from Harvard University and an M.B.A. and Ph.D. from the Wharton School of the University of Pennsylvania.


Industry Thought Leaders: Agriculture

Entrepreneurs of leading emerging growth companies and industry focused investors who leverage their talent, influence and capital to identify and grow businesses will share their approach and industry insights.

  • Isaac Bentwich, Chairman of CropX, an Ag-analytics company that empowers farmers to grow more crop with less water, using a simple, scalable software-as-a-service solution integrated with wireless sensors, that optimizes irrigation, applying different amounts of water to different parts of a field.
  • John Denniston, Chairman of Shared-X, an agriculture impact company aiming to generate strong investor returns, while at the same time lift thousands of smallholder farmers out of poverty, by collapsing the dramatic yield gap separating developed and emerging country crop production through the deployment of advanced, sustainable farming techniques. John was previously a Senior Partner at the Silicon Valley venture capital firm Kleiner Perkins Caufield & Byers, where he co-founded and co-ran the firm’s $1 billion Green Growth Fund. KPCB’s Green Growth Fund invests in sustainability companies in their growth stage. Prior to Kleiner Perkins, John was a Managing Director and Head of Technology Investment Banking for the Western United States at Salomon Smith Barney. He also served on the Investment Committees for Salomon’s venture capital/private equity direct investment fund, as well as CitiGroup’s venture capital fund-of-funds. Earlier in his career, John was a Partner with a large law firm, where he was Head of the firm’s Venture Capital practice, and Co-Head of its Information Technology practice group.
  • Anil Kapuria is Founder of, Inc., a social enterprise that infuses farm data analytics technology in the global farm value chain to stream line operations for small family farmers. Connected Agriculture is about leveling the field for over 550-million women farmers, about 70% of the total. They feed the world by growing the crops on less than 2.5 acres of land. In most cases their land is less productive, yet they are the backbone of world’s food supply chain and also of their families. Due to inherent biases arising out of age-old traditions, very few have any land rights, and are unable to get farm credits. They have limited access to improved inputs, like seeds, fertilizers, farm equipment, etc. Despite being equally productive, crop yields and prices they realize are lower than their male counterparts. Connected Agriculture for them should enable them to: (a) organize and manage cooperatives, community based formal markets, and value-added products to realize better prices; (b) collaborate with each other and share common costs; and (c) widen their market reach. It should also enhance their knowledge to improve crop yields, and the health and education of their family. is hosted in the Cloud. It globally empowers women farmers through a low cost smart mobile device that can be now charged even with the solar power. It is a social-enterprise with the mission to infuse ICT and the power of Data Analytics throughout their local farm value chains, so that the connected women farmers can better manage their farms, crops, markets and family welfare.
  • Ted Levinson, Founder and CEO of Beneficial Returns, a new impact investing debt fund supporting the growth of leading social enterprises that operate in emerging markets. Beneficial Returns provides loans of $75,000 to $500,000 for revenue-producing and cost-saving equipment to social enterprises focused on sustainable agriculture and energy, waste reduction and re-purposing and poverty alleviation.
  • Paul Matteuci, Operating Partner of U.S. Venture Partners, an investment firm that has invested over $2.7 billion in more than 450 companies, which in turn have created more than 100,000 jobs. USVP invests primarily in information technology and health care, though the firm is always open to disruptive ideas in other domains. Paul is also Co-Founder of Food System 6, which is enabling the best entrepreneurs to revolutionize the way we produce and distribute food globally.
  • Naveen Sikka, Founder & CEO of Terviva. The company’s mission in a nut shell is to use land better by revitalizing abandoned farmland. We need to produce more food in the next 3 decades than we have in the entirety of human history; but we lose millions of acres of arable land each year. Over the past 6 years, TerViva has aggregated a germplasm library of high-yield varieties of a leguminous tree crop, called pongamia, that produces vegetable oil and protein.


Industry Thought Leaders: Healthcare

Entrepreneurs of leading emerging growth companies and industry focused investors who leverage their talent, influence and capital to identify and grow businesses will share their approach and industry insights.

  • Kumaril (Kumar) Bhargava, Ph.D., MBA, R.Ph., Executive Director of Merck, where he is responsible for scouting and evaluating products in emerging science such as microbiome, regenerative medicine, hearing loss and gene therapy. He is also focused on out-licensed products and technologies to large and small biotech companies. He joined Merck after serving as a Founder and Chief Executive Officer of OncoViRx, a specialty company he started after licensing compounds for blood cancer from University of Pennsylvania. Prior to OncoViRx, Dr. Bhargava was part of the External Research & Development Innovation group at Pfizer where he played a key role in acquiring multiple technologies and companies in Rare and Orphan Diseases areas and establishing collaborations with biotech firms and academia. He also served as a Director of Strategic Marketing for Procrit™ at Johnson & Johnson. He has more than twenty years of experience in R&D, Supply Chain, Sales and marketing and Business development gained at Pfizer, Johnson & Johnson and Abbott.
  • David Darling, CEO of Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer.
  • David Foster, Director of IGXBio, a private biotechnology company developing vaccine-based therapeutics as an HIV therapy. The GenePro is a complex therapeutic DNA based composition that is combined with a TriGrid electroporation delivery system. The Company plans to initiate a Phase 1/2a clinical trial in 2017 hoping to have their product reconstitute the immune system, so that the natural immune defenses can be activated and locate and attack the virus. Animal trials have demonstrated that GenePro can generate CD8 memory cells, an important factor in HIV suppression.
  • Michael Joos, CEO of Spectrum Dynamics, which has developed an innovative high definition functional imaging technology that allows high-speed, high-resolution nuclear images in a compact system. Single Photon Emission Computer Tomography is used to image function. Spectrum Dynamics is a leader in cardiac SPECT imaging. The Company’s Broadview Technology utilizes a new scanning scheme and novel image reconstruction algorithms that enable a ten fold increase in sensitivity and significant improvement in image reconstruction quality and spectral resolution. Spectrum’s twelve non-rotating robotic telescoping arms come out from the system to hug or contour the patient’s body, allowing for clearer images, faster scanning, lower radiation dosing, and lower engineering costs.
  • Donald McCaffrey, CEO of Resverlogix, a public Biotechnology company developing small molecule selective BET Bromodomain and extra terminal inhibitors based on epigenetics pathways that regulate disease-causing genes. The lead product Apabetalone is currently in a Phase III trial treating high risk cardiovascular disease and type 2 Diabetes Mellitus patients. Subsequent products will focus on cardiovascular disease, kidney disease, and diabetes.
  • Paul Molloy, CEO of ClearFlow, a private Medical Technology Company that has developed novel drainage catheter evacuation systems. The lead product, PleuraFlow® Active Clearance Technology (ACT), proactively maintains drainage-catheter patency to provide optimal evacuation of blood and fluids from the chest cavity. Studies have shown the ACT system reduces Retained Blood Syndrome and Postoperative Atrial Fibrillation. Subsequent products will include ACTs for urinary catheters, gastrointestinal catheters, and wound drainage.


Industry Thought Leaders: Technology

Entrepreneurs of leading emerging growth companies and industry focused investors who leverage their talent, influence and capital to identify and grow businesses will share their approach and industry insights.

  • Jeff Habib, CEO of Causemo, a best-in-class donor management system that provides scale and management tools to charitable organizations, NGOs, foundations, and endowments. It provides these organizations with the ability to drill-down and perform bottom up analysis of their donor information to create compelling strategies to grow and optimize their most valuable relationships. Through a tightly integrated set of tools and dashboards, Causemo allows its clients to develop greater transparency into which donors are most valuable and to identify the best sources for donations and the best avenues to reach the donors with the highest ROCD – Return on Charitable Dollar.
  • Chris Macomber, CEO of WhoKnows, a People Analytics Platform Based on Always Accurate Employee Skills. Do you know who knows what across the globe, divisions, departments or even in the next cube? Enterprises around the world use WhoKnows to map and identify talent, assemble teams and track performance. Our customers now have the most accurate employee skills profiles and inventory, talent analytics platform for workforce planning and tools to make better decisions when it comes to understanding skills gaps, staffing and employee retention. Plug and play from day one, we help you leverage the habits of your employees and existing software (Social Collaboration, Social CRM and HRIS) instead of working around them.
  • Scott Norman, Founder & Managing Partner of Velorum Capital, a seed-stage venture capital firm based in San Francisco, focused on bringing industry into the 21st century through the convergence of hardware, software, and data analytics. We invest in industrial-scale technology including manufacturing, construction, aerospace, robotics & automation, sensors and instrumentation, and engineering tools.
  • Atiq Raza, CEO of Virsec, a Silicon Valley based company founded in early 2015 after 6 years (2009-2015) of stealth patent filings and technology development by successful technology focused entrepreneurs. Virsec has developed an proprietary attack detection and prevention platform. The ARMAS™ solution protects against data breaches at the application-layer, and sophisticated cyber-attacks that can happen in memory on underlying app infrastructure binaries. No other application security solution provides as deep and broad a protection as ARMAS.


The Self-Driving Revolution Will Be Here Sooner Than You Think

The autonomous vehicle market is still underhyped. Next to the Internet, it’s the most profound and transformative technology innovation in our lifetimes. Most people predict it will be 20 years or more until true, level 4 or level 5 autonomous vehicles will be on the roads. But it’s going to happen much sooner.


  • Jim Scheinman, Founding Managing Partner of Maven Ventures, has achieved 4 ‘unicorn’-level successes over the past 20 years as a founder, executive, and investor. His top performers include Cruise ($1B sale to GM), Bebo ($850M sale to AOL), Tango ($1B+ valuation), and NBCi ($6B IPO), plus several other exits including the recent acquisition of Check by Intuit for $360M. Jim is one of the leading growth experts in Silicon Valley, a TED speaker, and a frequent presenter and judge at many startup conferences and events. Jim has a BS in Neuropsychology from Duke University and earned a JD at the University of California Davis School of Law. Jim has startup in his blood. He’s been a serial entrepreneur dating back to his high school and college days.


Conversational Computing and Authentic Human Interaction in the Digital Age

As the world has become increasingly digital, we harbor the illusion that we are more connected: We’re always available, always communicating, always sharing and always on. But does this increase in internet connectivity actually lead to more connection with the people and things we love? To stronger emotional ties? It seems conversations have been replaced with transactional texts and human interactions have lost their way in the increasingly-complex social-interaction maze.

As we enter a new era of human-computing interaction in which conversational computing emerges as the most convenient and accessible interface, much will be disrupted. In this candid, forward-looking talk on evolving interfaces, interaction paradigms, and communication habits, Ari will explore emerging trends and opportunities related to messaging and human communication.


  • Ari Roisman, Co-Founder and CEO of Glide, a private, Consumer Technology Company that has created a unique visual communication ecosystem through the symbiosis of a novel hardware device and an innovative software platform. The result is a paradigmatic shift into a new era of ubiquitous, multi-sensory communication. Glide’s initial product, the Glide app, supports lightning-fast, private video messaging that utilizes cloud storage, so messages do not take up space on your device. The latest product, CMRA, is a smart watch wristband that houses self-facing and outward-facing HD cameras that enable hands-free video chat and lightning fast photos. Essentially, Glide has finally delivered on the long-awaited Dick Tracy wrist communication experience. Glide’s wrist camera, CMRA, enables the launch of the photo and video app ecosystem for the rapidly growing swartwatch market (In less than 2 years of sales, Apple is already the world’s largest watchmaker, behind Rolex, with ~20M Apple Watches shipped to date). MIT Technology Review recently named Ari Roisman, Glide’s Founder and CEO, as a 35 under 35 Innovator.


Maximizing Impact Investing in Non-Intuitive Ways
  • Michael McCullough, is an entrepreneur, impact investor, Co-Founder and Partner at Capricorn Healthcare, social entrepreneur, and emergency room physician. Michael’s personal interest in the brain extends from a childhood brain hemorrhage which resulted in hydrocephalus and a severe stutter, corrected by brain surgery at age 10 and requiring Michael to retrain himself to speak through high school and early college at Stanford. Accomplishing fluent speech also required extensive biofeedback and meditation practice. Michael recently hosted the inaugural  BrainMind Summit at Stanford University and soon Cambridge, bringing together researchers and entrepreneurs on the cutting edge of neuroscience. Dr. McCullough is also the co-founder of BrainMind. After returning from Oxford as a Rhodes Scholar, Michael co-founded QuestBridge during free hours in medical school at UCSF and his emergency medicine residency at Stanford. QuestBridge, a national non-profit, now places more talented low-income students into top colleges like Stanford, Yale, Caltech, and MIT than all other similar non-profits combined. Michael has since founded or co-founded 12 successful companies and non-profits. Michael is a founder of  RegenMed Systems, a co-founding investor of  HeartFlow, and on the founding board of 2U, — all top performing impact investments. Michael also served/serves on the boards of the Metabiota, Apnicure, the Global Leadership Incubator, QuestBridge, and the Dalai Lama Foundation among others, and serves as an on-call ER physician for the Dalai Lama during his visits to the West Coast.
The Future of Healthcare: The Real Evolution in Life Sciences, Aging & the Business of Healthcare is Ahead of Us

Not long ago, consumers could access health information about as easily as they could access plutonium. This is changing rapidly in the information age. As a result, consumers—rather than doctors, government, insurers, hospitals, or healthcare companies—will own the Healthcare Century. Any healthcare institution that ignores this trend does so at its peril.


  • Dr. Joon Yun, President of Palo Alto Investors, an investment management firm founded in 1989 with $1.8 billion in assets invested in healthcare. Board certified in Radiology, Joon served on the clinical faculty at Stanford from 2000-2006. He received his B.A. from Harvard, M.D. from Duke Medical School, and clinical training at Stanford. Joon has served on several corporate and non-profit boards, and has published dozens of patents, scientific articles, and business essays. He is a contributor to Forbes, and is the health editor for Evolution magazine. Joon recently agreed to donate a $1million Palo Alto Prize to reverse the aging process.
Advances in Stem Cell Research

“Today, for the first time in history, stem cell research offers real hope to those whose suffering has previously been considered incurable. The road is long and challenging, but scientists and physician-scientists, empowered by the people of California, have accomplished much. The path to success is within our grasp, if we can sustain the advances of the scientists dedicated to stem cell therapies.” – Americans for Cures


  • Bob Klein is President of  Klein Financial Corporation, a real estate investment banking consulting company focused on affordable housing finance and development. The company has raised and/or consulted on approximately $3 billion in financing and development of public and private real estate projects and governmental housing funding programs. Bob is also Chairman Emeritus of the California Institute of Regenerative Medicine (CIRM), which is accelerating stem cell treatments to patients with unmet medical needs, and he serves as Board Director of  Lifeguard Health Networks, a company with a mission to simplify care coordination by harnessing the collective information & power of all Caregivers. Bob is committed to advancing medical research. Bob served as author of  Proposition 71 and as Chairman of the California Proposition 71 campaign committee, the champion sponsor of the $3 billion dollar “California Stem Cell Research and Cures” ballot initiative. This initiative supports stem cell research for chronic illness and injury, with a focus on pluripotent and progenitor stem cell research. Time Magazine honored Bob as “One of the World’s 100 Most Influential People of the Year” for 2005. Soon after, Scientific American named Bob one of “The Scientific American 50” as a leader shaping the future of science technology. Bob holds a B.A. in History from Stanford University and JD from Stanford University Law School.
Life Extension; Using Biological Research to Reduce or Reverse the Effects of Aging

“We’re in the midst of an extraordinary fight and we need every ounce of manpower we can muster, but the good news is, should we succeed,
we’ll have turned the most awful paradigm that we know on it’s head… that is to say, the inevitability of death.” – Laura Deming



  • Laura Deming, is Partner of The Longevity Fund, which finds and funds companies that aim to extend the period of healthy human life and ameliorate age-related decline in physical function. Managed by former executives and fund managers with a track record of success in the pharma industry, the Fund seeks to capitalize on innovation-based opportunity wherever it finds it. When she was 8, Laura realized that we were all going to die of a disease called aging. Ever since, her driving passion has been to slow aging and eliminate age-related disease. She started working in a biogerontology lab when she was 12, and matriculated at MIT when she was 14. At 17, she was one of the youngest 20under20 fellows awarded $100,000 by Peter Thiel to pursue her venture full time. Laura is currently a full-time partner at The Longevity Fund, an early stage venture capital fund backing companies which target the aging process to treat disease, with investments in gene editing, small molecule therapeutics, and novel methods to treat disease.


Global Threats to Ecosystems, Societies, Economies, and the Solutions

Threats that were once on the periphery of investor calculations now have the potential to not only cause serious disruption to otherwise well-thought out investment plans, but to the existence of species. Challenges that threaten humanity’s survival require innovative responses and insights. The power of collaboration can ensure a prosperous future. Experts discuss the nature of the challenges we face today, and how to respond to and contain these threats.


  • Ilmi Granoff, Senior Research Associate of and leads green growth at Overseas Development Institute, the UK’s leading independent think tank on international development and humanitarian issues. He is also Director of Sustainable Finance of  ClimateWorks Foundation, a team of researchers, strategists, collaborators, and grant-makers who are committed to climate action and believe in the power of collective philanthropy.
  • Jonathan Granoff, President of Global Security Institute, is an international lawyer and former professor of international law, and serves as a Senior Advisor and Special Representative to the United Nations for the Permanent Secretariat of the World Summit of Nobel Peace Laureates. He is the Chair of the Task Force on Nuclear Nonproliferation of the International Law Section of the American Bar Association, and Ambassador for Peace and Security of the Parliament of the World’s Religions. He focuses his advocacy efforts on the legal, moral, political and spiritual dimensions of peace with a particular emphasis on the rule of law and the elimination of nuclear weapons. He serves on numerous advisory and governing boards such as the NGO Committee on Disarmament, Peace and Security at the UN, Lawyers Committee on Nuclear Policy, Middle Powers Initiative, Parliamentarians for Nuclear Nonproliferation and Disarmament, and the Jane Goodall Institute. He is a Fellow in the World Academy of Arts and Science and recipient of numerous awards such as the Arthur E. Armitage, Sr. Distinguished Alumni Award of Rutgers University School of Law. Mr. Granoff is the award-winning screenwriter of The Constitution: The Document that Created a Nation, and has articles in more than 50 publications and books including: The Sovereignty Revolution, Toward a Nuclear Weapons Free World, Imagining Tomorrow, Analyzing Moral Issues, Perspectives on 911, Toward a World In Balance, Reverence for Life Revisited, and Hold Hope, Wage Peace. He has been a featured guest and expert commentator on hundreds of radio and television programs, and testified as an expert in the US Congress, Parliaments of the UK and Canada, and at the UN numerous times. He has represented the Nobel Laureate organization the International Peace Bureau at Nobel Laureate Summits and was nominated for the Nobel Peace Prize in 2014.

Americans for Cures

Our mission at Americans for Cures is to advocate for stem cell research and therapy development; and, ultimately, to improve the lives of patients and their families suffering from chronic disease and injury.

It is critical that the public is aware of the breakthroughs in stem cell research and therapy developments that have resulted from the passage of Proposition 71: the California Stem Cell Research and Cures Initiative. We at the Americans for Cures Foundation believe it is our responsibility to report back to the 7 million Californians—including 70+ patient advocacy organizations, 30+ Nobel Laureates, 150+ elected officials, 30+ Chambers of Commerce, business and labor groups, and many other key opinion leaders—who voted in support of Proposition 71.

To accomplish this goal, Americans for Cures is driving a patient advocate-led “Report Back to the Public” communications program to empower patient advocates, and to increase public awareness of breakthroughs in stem cell research and therapy development. As part of this Report Back to the Public, Americans for Cures develops accurate, educational content—all of which is vetted by its Scientific Advisory Board, which is comprised of 25 of California’s leading scientists and physician-scientists—and then disseminates that content to the public through a variety of platforms, including social media, online blogs, paid and earned media, patient advocacy organization networks and more.

Americans for Cures provides information and tools to advocates for stem cell research, to empower them and assist with their efforts to:

  • Distribute factual information about stem cell research;
  • Communicate effectively;
  • Encourage decision-makers to fund research and translate medical research breakthroughs into therapies for patients; and,
  • Find strength and hope in our shared vision and mission to improve the human condition and reduce suffering.

Today, for the first time in history, stem cell research offers real hope to those whose suffering has previously been considered incurable. The road is long and challenging, but scientists and physician-scientists, empowered by the people of California, have accomplished much. The path to success is within our grasp, if we can sustain the advances of the scientists dedicated to stem cell therapies.


Girls Gone Global

Girls Gone Global is all about helping girls make the world around them better. By developing their leadership and problem solving skills through our multi-component tool-kit and community platform, we unleash their creativity and build their inner social impact champion. Our media skill-builder will enlighten, encourage and empower them to get the word out about the work they and their friends are doing. Every classroom and living room can become a social impact hub within a few hours.

Girls Gone Global ignites and empowers confidence and leadership within girls around the world to own their inner voice, speak their truth, and drive meaningful and positive change to make their world a better place.

Girls Gone Global


Global Security Institute
United Nations Office
866 United Nations Plaza
Suite 4050
New York, NY 10017
Phone: (646) 289-5170


Sonoma Ecology Center
P.O. Box 1486
Eldridge, CA 95431
Phone: (707) 996-0712


General Session
9:00 9:30 Maximizing Impact Investing in Non-Intuitive Ways
9:30 10:00 Advances in Stem Cell Research
10:00 10:15 Americans for Cures Foundation
10:15 10:45 Conversational Computing and Authentic Human Interaction in the Digital Age
10:45 11:15 Life Extension, Using Biological Research to Reduce or Reverse the Effects of Aging
11:15 11:30 Girls Gone Global - Igniting girls leadership, problem solving skills and voices for a better world
11:30 12:00 The Future of Healthcare: The Real Evolution in Life Sciences, Aging & the Business of Healthcare is Ahead of Us
12:00 12:30 The Self-Driving Revolution Will Be Here Sooner Than You Think
12:30 14:00 Networking Luncheon
14:00 14:30 Industry Outlook Panel - Agriculture
14:30 15:00 Industry Outlook Panel - Healthcare
15:00 15:30 Industry Outlook Panel - Technology
15:30 16:00 Global Threats to Ecosystems, Societies, Economies, and the Solutions
16:00 16:30 Family Office Roundtable
18:00 21:00  Networking Dinner Reception



Fairmont Sonoma Mission Inn & Spa
100 Boyes Blvd
Sonoma, CA 95476
(703) 938-9000

Make A Reservation

Dinner Venue: Sonoma Valley Room

100 Boyes Blvd
Sonoma, CA 95476
(703) 938-9000



DATE Time Departure Time Arrival(estimated) Hours of service Location Departure Location Arrival Location Arrival
12th January
5:00 PM 7:00 PM Shuttle will drop off guests at Fairmont Sonoma for dinner Marriot Union Square
480 Sutter Street
San Francisco, CA 94108
Fairmont Sonoma
Mission Inn & Spa
100 Boyes Blvd.
Sonoma, CA 95476
13th January
12:20 PM 12:25 PM Shuttle will drop off guests at Golf Club for focused industry luncheons Fairmont Sonoma
Mission Inn & Spa
100 Boyes Blvd.
Sonoma, CA 95476
Sonoma Golf Club
17700 Arnold Drive
Sonoma, CA 95476
13th January
2:00 PM 2:05 PM Shuttle will drop off guests at Sonoma for the conference Sonoma Golf Club
17700 Arnold Drive
Sonoma, CA 95476
Fairmont Sonoma
Mission Inn & Spa
100 Boyes Blvd.
Sonoma, CA 95476
14th January
8:45 AM 10:30 AM Shuttle will drop off guests at Union Square and then SFO International Airport Fairmont Sonoma
Mission Inn & Spa
100 Boyes Blvd.
Sonoma, CA 95476
Marriot Union Square
480 Sutter Street
San Francisco, CA 94108
SFO International Airport